Fidelity International’s Eurozone
Select Real Estate Fund acquired
the Mirai House property at
Leiden Bio Science Park in the
Netherlands in December 2020.
Mirai House is a high-tech mixeduse R&D complex with a total
surface area of approximately
15,000 sq m (161,400 sq ft). The
building, which was commissioned
and developed for Astellas in
2012, is leased on a long-term
basis to strong tenants under
10- and 15-year contracts.
Pharmaceutical company Astellas,
which was already housed in the
office wing, has rented it back. The
laboratory wing is leased to the
Leiden University Medical Center
(LUMC) and the Netherlands
Center for the Clinical
advancement of Stem Cell and
Gene Therapies (NECSTGEN).
We caught up with Maarten
Frouws in Amsterdam.
Tell us a bit about yourself and your background. Where did you work prior to FIL?
Before joining Fidelity International I worked at Bouwfonds Investment Management, a subsidiary of Rabobank at the time, where I focused on research, business development and acquisitions, mostly in the Netherlands but also in Germany, Belgium, France and the UK.
